Renibus Therapeutics

Southlake, United States

Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.

$25.0M raised

Sep 2023

Series B

Biotechnology Health Care Therapeutics

Top Investors

Oxford Finance LLC

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Renibus Therapeutics

How much funding has Renibus Therapeutics raised?

Renibus Therapeutics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in September 2023.

Who are Renibus Therapeutics's investors?

Renibus Therapeutics's investors include Oxford Finance LLC.

Where is Renibus Therapeutics headquartered?

Renibus Therapeutics is headquartered in Southlake, United States.

What does Renibus Therapeutics do?

Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.

What stage is Renibus Therapeutics at?

Renibus Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 12, 2023.

MLA

"Renibus Therapeutics — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/renibus-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Renibus Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/renibus-therapeutics

Wikipedia (cite web)

{{cite web |title=Renibus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/renibus-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 12, 2023.